Planned Parenthood* 3727 NE Martin Luther Kings Bd. Portland, Oregon 97212 p: 808.775.4931 -f: 503.788.7285 Care. No matter what. wun ppew.org Planned Parenthood Columbia Willamette ‘STACY M. Cross, MBA Presibenr& CEO Lane PaexTi}000 CouLMMaIA WaLLAMETTE October 6, 2015 VIA EMAIL AND FIRST CLASS MAIL, Representative Dallas Heard trict 2 - Roseburg 900 Court St. NE H-386 Salem, Oregon 97301 rep.dallasheard@state.or.us Representative Andy Olson District 15 - Albany 900 Court St. NE H-478 Salem, OR 97301 rep.andyolson@state.or.us Representative Jim Weidner District 24 - Yamhill 900 Court St. NE H-387 Salem, OR 97301 rep jimweidner@state.or.us Representative Bill Kennemer District 39 - Oregon City 900 Court St. NE H-380 Salem, OR 97301 rep.billkennemer@state.or.us : $03.788,7270 503.788.7285, Wor RFCW.0RG Representative Cedric Hayden District 7 - Roseburg 900 Court St. NE H-379 Salem, OR 97301 rep.cedrichayden@state.or.us Representative Jodi Hack District 19 - Salem 900 Court St. NE H-385 Salem, OR 97301 rep jodihack@state.or.us Representative Bill Post District 25 - Keizer 900 Court St NE H-373 Salem, OR 97301 rep billpost@state.or.us Representative Gail Whitsett District 56 - Klamath Falls, 900 Court St NE H-474 Salem, OR 97301 rep.gailwhitsett@state.orus Re: Planned Parenthood of the Columbia Willamette Dear Representatives: We are writing to respond to your letter of September 29, 2015 regarding Planned Parenthood of the Columbia Willamette (“PPCW"), which provides high-quality reproductive health care and information to the citizens of Oregon. Your questions focus on our involvement in medical research, which is a very small part of what we do in relation to the various health services we provide, including high-quality affordable birth control, lifesaving cancer screenings, testing and ‘treatment of sexually transmitted infections, and other essential care, Although itis only a small tax © 0amOregon State Representatives October 6, 2015 Page 2 part of what we do, we are proud of the limited role we play in medical research and are pleased to answer your questions in the same order as they are set forth in your letter. 1. As you know, PPCW does not participate in any research studies focused on fetal tissue. However, PPCW does participate in two research studies conducted by Oregon Health & Science University (*OHSU") that involve evaluating first-trimester placental tissue, one seeking in part to prevent eetopie pregnancy, and one seeking to predict the risk for certain health issues that are related to poor placental blood flow. PPCW patients who wish to do so have the option of donating placental tissue for use in those studies, OHSU, to whom you have also written, is in the best position to describe the nature of the placental tissue collected in such studies as well as the tissue collection process. Tissue that is not collected, including embryonic or fetal tissue, is handled in accordance with applicable legal requirements. PPCW does not profit from participating in the studies and is not paid for individual tissue samples, On the contrary, the only funds PPCW receives are designed to reimburse it for certain ses associated with participating in the studies. For the first study, PPCW received a flat y use fee as reimbursement for the use of space, including equipment storage space and an exam room. ‘The study also allows PPCW to seck reimbursement for the use of a study coordinator on an hourly basis in an amount up to $5,000, as well as for ancillary medical supplies in an amount up to $2,500, although the actual amounts invoiced and received have been far less. With regard to the second study, PPCW received a similar flat facility use fee of $6,500 solely for providing office space with access to a computer, as well as lab space and IT support. None of these payments were made for specimens, nor were they made on a per specimen basis. 2, PPCW has never altered the timing, method, or abortion procedure to facilitate fetal tissue donations to OHSU or any other organization. 3. PPCW lacks the information necessary to respond to this question, which is directed at OHSU rather than PPCW. 4. PPCW has never provided fetal tissue to ABR. The remainder of this question is directed at OHSU rather than PCW, 5. PPCW has never provided fetal tissue from fetuses aborted during the second or third trimesters of pregnancy to any research organizations. Again, the remainder of this question is directed at OHSU, rather than PPCW.Oregon State Representatives October 6, 2015 Page 3 We trust that this letter answers all of your questions. Stacy M. Cross, MBA President and CEO Planned Parenthood Columbia Willamette Regards, SMC:par ce: Lisa Gardner Joseph Robertson Jr., M.D., M.B.A Daniel Dorsa, Ph.D.